Ramirez Asset Management »

Crispr Therapeutics shares owned by Ramirez Asset Management

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Ramirez Asset Management from 13F filings

Historical chart of Ramirez Asset Management investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Ramirez Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Ramirez Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $26k 500 52.44